Short therapy shows promise in preventing repeat suicide attempts

NCT ID NCT03894462

Completed Disease control Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a short, three-session therapy program called ASSIP for adults who have attempted suicide within the past 60 days. The therapy helps participants understand the feelings and events leading up to their attempt and create a personalized safety plan. Researchers want to see if this low-cost approach can reduce the chance of another suicide attempt compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Attempted Suicide Short Intervention Program (ASSIP) - a brief, manualized behavioral therapy delivered in three sessions
What this could lead to: If effective, this could provide a practical, low-cost therapy that reduces suicide reattempts in real-world healthcare settings.
What could go wrong: This is a single study in one health system, and results may not apply everywhere. The therapy may not work for everyone, and some participants might still attempt suicide.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE, ATTEMPTED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDE, ATTEMPTED

Contacts and locations

Locations

St. Joseph's Health Hospital

Syracuse, New York, 13203, United States
University of Rochester Medical Center

Rochester, New York, 14604, United States
Upstate University Hospital

Syracuse, New York, 13210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.